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1. Introduction 
Cardiovascular disease (CVD) is a major factor in mortality rates around the world and 
contributes to more than one-third of deaths in the United States [1]. The distribution of 
blood volume to different parts of the human vascular system can be seen in Figure 1. CVDs 
are the world’s largest killers, claiming 17.1 million lives a year [1]. Tobacco use, an 
unhealthy diet, physical inactivity and harmful use of alcohol increase the risk of heart 
attacks and strokes [2]. Table 1 introduces the common risk factors of CVD.  In addition, 
Table 1 shows some common types of CVD risk factors. 
 
Fig. 1. Distribution of blood volume for the different parts of the human vascular system 
Source: [3] 
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Risk factor 
Risks can’t be 
changed 
Risks can be 
modified or treated 
Factors contribute 
to heart disease risk 
1 Increasing age Tobacco smoke Response to stress 
2 
Gender High blood 
cholesterol 
Drinking alcohol 
3 Heredity high blood pressure Smoking 
4 Family history Physical inactivity  
5  Obesity  
6  Diabetes mellitus  
Table 1. Common types of CVD risk factors 
The underlying cause of CV disease is atherosclerosis, a chronic inflammatory process that 
is clinically manifested as coronary artery disease, carotid artery disease, or peripheral 
artery disease [1; 4]. The frequency and prevalence of atherosclerosis are difficult to be 
assessed exactly. It has been predicted that atherosclerosis will be the primary cause of 
death in the world by 2020 [5]. Usually, atherosclerosis is an asymptomatic condition that 
might begin from childhood, whereas symptomatic organ-specific clinical manifestations 
often do not appear until 40 years of age or older when it is most commonly diagnosed [6]. 
Atherosclerosis can be characterized as a slow disease in which the arteries become 
hardened. In other words, it is characterized by the formation of arterial lesions or plaques 
as a result of an inflammatory response to endothelial injury [7]. Atherosclerosis eventually 
leads to artery enlargement, arterial stenosis, and may ultimately produce an arterial 
rupture [8]. The more commonly used subclinical vascular markers in the clinical setting are 
carotid intima media thickness (CIMT) and plaque measured by ultrasound, coronary artery 
calcium detected by cardiac computed tomography (CT), ankle–arm index pressure (AAI) 
measured by distal pressure Doppler measurement, and aortic pulse wave velocity (PWV) 
measured from carotid and femoral pressure wave recordings with a Doppler or 
mechanographic device [9-10]. Atherosclerosis can occur because of fatty deposits on the 
inner lining of arteries, calcification of the wall of the arteries, or thickening of the muscular 
wall of the arteries from chronically elevated blood pressure [11]. Atherosclerosis does not 
usually produce any symptoms until a CVD occurs. Therefore the prediction of 
atherosclerosis might contribute a lot to disease stratification and risk prevention. Figure 3 
represents the process of developing atherosclerosis in the carotid intima-media arteries. It 
seems clearly that, inflammation affects the formation of arteries and the propagation of 
blood stream as well. Endothelial dysfunction is observed in the early stages of the 
atherogenic process, and it is initiated by injury to the arterial endothelium [1]. Such injury 
has been associated with CV risk factors including diabetes mellitus or impaired glucose 
metabolism, hypertension, cigarette smoking, dyslipidemia, obesity, and/or metabolic 
syndrome [12]. Endothelial dysfunction is the initial step of the atherosclerotic process 
involving many vascular districts, including penile and coronary circulation [13]. 
Endothelial dysfunction is associated with CVD risk factors [14-15]. Endothelial dysfunction 
has been proposed to be an early event of patho-physiologic importance in the 
atherosclerotic process [16-17] and provides an important link between diseases such as 
hypertension, chronic renal failure, or diabetes and the high risk of cardiovascular events in 
patients exhibiting these conditions [18]. 
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Fig. 2. The process of atherosclerosis development in general. Source: [38] 
 
Fig. 3. Atherosclerosis risk at carotid intima-media arteries, Source: [39] 
Elevated blood pressure reflects the existence of atherosclerosis. There is irresistible 
evidence that high blood cholesterol increases the risk of developing atherosclerosis; but 
cholesterol is not the damaging mechanism. In fact, the risk of atherosclerosis is more 
precisely assessed by measuring the proportional association between HDL cholesterol and 
LDL cholesterol [18].  Stiffening of large arteries predicts adverse cardiovascular outcomes 
[19-21]. Until now, measurements of arterial stiffness required the use of complex 
www.intechopen.com
 
Erectile Dysfunction – Disease-Associated Mechanisms and Novel Insights into Therapy 
 
198 
ultrasound equipment or explanation tonometry at the level of the peripheral arteries, with 
the subjects in the supine or sitting position [22-23]. Medically, atherosclerosis is considered 
the dominant pattern of arteriosclerosis which affects primarily the elastic and large- to 
medium-sized muscular arteries. Therefore, hypertension is an established risk factor for the 
development of atherosclerosis [24]. Atherosclerosis is the term applied to a focal condition 
of the intima of arteries associated with medial changes. In fact, atherosclerosis can involve 
many of the body’s blood vessels with a variety of presentations [25].  Pathological and 
epidemiological data confirm that atherosclerosis begins in early childhood, and advances 
seamlessly and inexorably throughout life [26]. Risk factors in childhood are similar to those 
in adults, and track between stages of life. When diagnosed, aggressive treatment should 
begin at the earliest indication, and continue for years. For those patients at intermediate 
risk according to global risk scores, C-reactive protein (CRP), coronary artery calcium 
(CAC), and carotid intima-media thickness (CIMT) are available for further stratification.  
Atherosclerotic lesions develop slowly, but continuously leading to the main causes of 
mortality in diabetic patients such as coronary arterial disease, stroke, and renal failure [27]. 
In diabetic children, the presence of subclinical atherosclerotic disease as a precursor of 
macrovascular complications has been shown in several studies [28]. Also, impaired 
endothelial function preceding atherosclerotic changes has been observed [29]. As the 
measurement of the intima-media thickness of the carotid arteries is considered a surrogate 
marker of subclinical atherosclerosis, this method has been used widely in these patients to 
asses vascular health [28]. CIMT is a noninvasive and reproducible method to detect and 
quantify subclinical atherosclerosis [30]. Autopsy studies have demonstrated a direct 
histoligical relationship between carotid and coronary atherosclerosis [31-32]. CIMT 
measurements have been used to measure differences in the progression of atherosclerosis in 
clinical trials [33]. In observational trials, increased CIMT is associated with prevalent and 
incident cardiovascular disease [34-36]. Although ultrasound measurement of CIMT has been 
recommended as a clinical screening tool, its use has been limited to research studies or 
selected institutions, in part because of labor- and time-intensive measurement protocols [37]. 
Mainly, atherosclerosis starts with oxidation of LDL particles in the arterial wall [40-41]. 
Oxidative modified LDL (oxLDL) damages the endothelium of the artery - a 
pathophysiology similar to that of vascular erectile dysfunction (ED) [41-42]. As a result, the 
elasticity of the arteries deteriorates. Impaired arterial elasticity and increased levels of 
circulating oxLDL as well as elevated fibrinogen and resting heart rate associate with 
subclinical atherosclerosis and increased risk of cardiovascular disease (CVD) events [43-48]. 
Besides similar pathophysiology, ED and CVD share same risk factors [49]. In addition, a 
high prevalence of both silent and clinical CVD has been reported among ED patients [49-
50]. ED has also been reported as an independent predictor of incident CVD [51-52]. Since 
ED often precedes CVD symptoms from other vascular beds, it is thought to be an early 
clinical manifestation of systemic atherosclerosis [49; 53]. There is increasing evidence of a 
strong link between ED and atherosclerosis [54-55]. ED and atherosclerosis share similar risk 
factors and both conditions are characterized by endothelial dysfunction and impaired nitric 
oxide bioavailability [56]. Peripheral artery disease (PAD) as similar to ED is associated with 
atherosclerotic risk factors [57]. 
With advanced age, men experience decreases in important health indicators (muscle 
amount, muscle power, physical activity, bone density, blood generation, and sexual drive) 
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[58]. Various research [57-59] on the decrease in blood testosterone with aging suggests that 
many clinical characteristics related to age, including ED, are closely related to lack of 
testosterones. Recent research results indicate that testosterone and ED are closely related to 
one other [60-61], which suggests that supplementary therapy with testosterone may be one 
useful method in the treatment of ED [62]. However, the link between ED and 
atherosclerosis is well known to doctors. Doctors thought of atherosclerosis to be the main 
cause of ED. The thought was driven from the hypothesis that small arteries will be clotted 
before the large or medium ones. Since erection depends mainly on the amount of delivered 
blood to the penis, normal arteries thought to have no problem in supporting the process of 
blood delivering. In contrast, if the arteries become stiffen due to the deposition of 
atherosclerosis (which in turn will reduce their compliance as a result of the increment in 
arteries walls resistance), the amount of delivered blood will be declined which affects the 
process of erection. Atherosclerosis as an indicator of endothelium dysfunction, thought to 
be the underlying cause of CVDs and ED. Once the arteries start losing their elastic 
properties, the atherosclerosis is proven to be existed. The development of atherosclerosis 
prevents endothelial cell from regulating blood flow. Moreover, the accumulation of 
atherosclerosis affects the propagation of blood which can be detected by the recording of 
Photoplethysmogram (PPG) signal. PPG is an optoelectronic technique that reflects blood 
volume changes in arteries [63]. It functions by illuminating the skin with a light by light-
emitting diode (LED) and recording the scattered lights by a photodetector.  
ED as a vasculogenic disorder may indicate that, blood vessels anywhere in the body are not 
in perfect health. ED still has no establish method for diagnosing subjects to be subject with 
ED or normal subject (normal erection). Therefore, linking ED to atherosclerosis is the most 
acceptable thought in this area. ED may be a sign that coronary artery disease is developing 
some risk factors. That’s why; being under-risk of atherosclerosis raises the chance of 
experiencing ED at any age. The endothelium can be damaged by high cholesterol, high 
blood pressure, smoking, or diabetes. They also cause atherosclerosis. Once damaged, the 
endothelium can't expand arteries to increase blood flow as well. Less blood flow into the 
penis means a less tumescence and consequently no satisfactory erection. In this study, a 
sample of 68 ED patients were hired to run a research that aims to investigate and evaluate 
the associations between atherosclerosis and ED. The PPG signal was used to predict the 
high-risk of atherosclerosis. Its noteworthy that, CIMT test was used to evaluate the risk of 
atherosclerosis. Since the CIMT method continues to be a measure of atherosclerosis, the 
value of 0.7 was determined as the critical point. As a result, any value below or equal to 0.7 
(CIMT=<0.7mm) represents a normal case, otherwise, it represents a case under risk. And 
since the diagnostic test is used to reveal the health status of the subject, a new index 
derived from CIMT which is called high-risk atherosclerosis (HRART) was used to 
discriminate between at-risk-of-the-disease and normal subjects based on the critical value 
of 0.7.  Statistically, HRART was taken as the dependent variable. All subjects were from 
Urology clinic at the medical center of the National University of Malaysia (PPUKM).  
Thinking of atherosclerosis as the main cause that might cause ED represents a big 
motivation for the development of a predictive model for high-risk atherosclerosis 
assessment. Once atherosclerosis has been predicted, ED can be examined and checked by 
means of atherosclerosis. The measurement of CIMT and PPG were done at the same time. 
We started our research by hypothesizing that PPG is willing to predict high-risk 
atherosclerosis by utilizing PPG’s contour analysis technique. Since PPG reflects changes in 
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blood volume, it will be affected clearly by aging and by atherosclerosis. Therefore, the aim 
was to extract some indices from PPG waveform morphology and relate these indices to 
atherosclerosis measured by CIMT test. Since the pulsatile components of PPG waveform 
are the important features due to their ability to reflect blood flow and blood volume 
changes in the arteries, we paid extra attention to PPG amplitude indices without neglecting 
PPG time indices. Atherosclerosis plays an important role in the process of blood 
propagation and blood volume changes. As we age, PPG amplitude is subject to reduction 
because of the accumulated atherosclerosis, which in turn increases the resistance of arteries 
and reduces arterial compliance. It is noteworthy that, atherosclerosis affects the elastic 
properties of the arterial wall, making it stiffen. As arteries become stiffer, blood 
propagation becomes faster and pulse amplitude becomes lower as well. In this research 12 
main indices of PPG were extracted and evaluated Table 2 demonstrates the extracted 
parameters.  
 
Index B S.E. Wald df Sig. Exp (B) 
Age .071 .028 6.198 1 .013** 1.07 
BMI -.025 .058 .179 1 .673 .976 
SP .04 .024 2.7 1 .1 1.04 
DP -.017 .034 .25 1 .614 .98 
MAP .016 .033 .23 1 .634 1.02 
PP .071 .032 4.8 1 .028** 1.07 
H -.114 .045 6.3 1 .012** .89 
PT 1.02 1.6 .4 1 .52 2.76 
MET 52.8 32.5 2.6 1 .1 8.7E+22 
ST 15.4 6 6.57 1 .01** 4732574 
DT 4.96 6 .68 1 .41 143 
PPT -14.7 6.96 4.5 1 .034** .00 
SI .04 .087 .23 1 .63 1.04 
MEV -552.3 1231 .2 1 .65 .00 
PM -1.08 10.2 .01 1 .92 .338 
DM 1.76 15.2 .013 1 .9 5.8 
RI 1.78 1.9 .88 1 .35 5.9 
b/a -5.43 1.88 8.3 1 .004** 72.6 
c/a -.073 3.75 .00 1 .98 .93 
Note: Each index was tested separately to obtain any statistically significant against the dependent 
variable. The table represents their collection.  
Table 2. Initial variables tested for model development 
Given the importance of the medical data in pathogenesis of atherosclerosis, clinical interest 
has focused on the development of markers of risk. Therefore, blood pressure (SP, DP, PP, 
and MAP) in addition to body mass index were recorded as well. Among the medical data 
measurements mentioned, PP was found to be a significant factor contributing to the 
process of atherosclerosis. PP is an independent predictor of myocardial infarction (MI) [64]. 
The progression of atherosclerosis is accompanied by an increase in PP [65].  Our results 
supported such an observations by revealing a positively association between PP and 
atherosclerosis.  
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In addition, subject’s height (H) was inversely correlated with atherosclerosis in our results. 
Height was inversely associated with risk of MI [66], and an inverse association between 
height and risk of coronary heart disease (CHD) has been reported in several analytic 
studies [67-68]. Therefore, H and PP were statistically significant in this research. Detail on 
H and PP characteristics in the follow sections.   
Basically, the first attention was to utilize PPG technique only in the assessment of high-risk 
atherosclerosis. But, as a result from the final research, PP and H were contributable to the 
risk of atherosclerosis. Which in turn resulted in a predictive model represents the 
contribution of PPG (b/a ratio), PP and H to the development of atherosclerosis. Obviously, 
it is worthy to investigate the contribution of PPG (b/a ratio) alone to atherosclerosis and 
the contribution of PP, H and PPG (b/a ratio) together. To make these investigations 
achieved, we conducted the analysis of logistic regression (Backward: LR). Logistic 
regression (LR) is used normally to model the relationship between a binary response 
variable and one or more predictor variables, which may either be discrete or continuous. 
Binary outcome data is common in medical applications. In our work, the binary response 
variable might be whether or not a patient is at risk of atherosclerosis. In multiple 
regressions, we are concerned with finding an appropriate combination of predictor 
variables to help explain the binary outcome. However, a logistic regression model was 
developed to assist in the early prediction of high-risk atherosclerosis, and to be used as an 
alternative rapid measure for screening for atherosclerosis. 
The developed model went through three main methods of logistic regression. The first 
method (ENTER: LR) was used to test the significance of each index separately against the 
dependent variable, Risk of atherosclerosis initiated from CIMT test. The second method 
(Forward: LR) was used to test the significance of the significant indices against the 
dependent variable. The final method (Backward: LR) was used to test the significance of 
the significant indices against the dependent variable as well. Both forward and backward 
methods were used for the same techniques and they were fed with the same significant 
indices; and the one with a higher performance in terms of (Nagelkerke R-square and 
likelihood ratio) was used to implement the final model.  The results revealed that some 
indices (age, PP, H, PPT, ST, and b/a) were statistically significant and that they could be 
used to initiate the model. The six chosen indices were fed to forward: LR and backward: LR 
methods. Table 3 shows the associated Nagelkerke R-square for each variable. 
 
Index  R-square Likelihood-ratio 
Age .133 87.14 
PP .11 88.4 
H .138 86.8 
PPT .094 89.3 
ST .135 87 
b/a .184 84.2 
Note: R-square represents the amount that this index contributes to the process of high-risk of 
atherosclerosis.  
Table 3. Nagelkerke R-square for the selected indices 
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However, to investigate the effects of the multiple variables together in the model, the 
forward: LR method was used first. After feeding the model with all the chosen variables, 
forward: LR responded as follows:  
 Two out of six indices remained in the model (b/a and H), therefore age, PP, PPT, and 
ST were excluded from the calculations. Table 4 illustrates the model summary of the 
forward: LR method. 
 The model revealed a value of Nagelkerke R-square (.288) and a likelihood ratio of 77.69 
 Step 2, forward: LR was chosen to represent the model based on this method. 
 
Step -2 Log likelihood 
Cox & Snell R 
Square 
Nagelkerke R 
Square 
1 84.179 .138 .184 
2 77.694 .216 .288 
Note: Step 2 is used to represent the final decision about the model 
Table 4. Model summary of forward: LR 
On the other hand, backward: LR responded better than the forward: LR method. The 
model revealed a higher Nagelkerke R-square value (.372). A summary of the model is 
shown in Table 5. After feeding the model with all chosen variables, backward: LR 
responded as follows:  
 Three out of six indices remained in the model (b/a, PP, and H); Therefore PPT, age and 
ST were excluded from the calculations. Table 5 illustrates the model summary of the 
backward: LR method. 
 The model revealed a value of Nagelkerke R-square (.372) and a likelihood ratio of 74 
 Step 4 backward: LR was chosen to represent the model based on this method. 
 
Step -2 Log likelihood 
Cox & Snell R 
Square 
Nagelkerke R 
Square 
1 71 .287 .383 
2 71 .287 .383 
3 72 .279 .372 
4 74 .258 .372 
Note: Step 4 was used to represent the final decision about the model 
Table 5. Model summary of backward: LR 
Moreover, it is helpful to demonstrate the relationship between the predicted outcome and 
certain characteristics found in observations. Table 6 represents the final characteristics of 
the developed model. 
Our chief interest was to use the logistic model to predict the outcome for a new subject. 
How good was this model for prediction? When we have a new subject, we can use the 
logistic model to predict his probability of having high-risk atherosclerosis. Let us say we 
have a black box where we input the b/a index, PP and H of a subject and the output is a 
number between 0 and 1 which denotes the probability of the subject having a high-risk of 
atherosclerosis (Figure 4). 
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       95% C.I.for 
EXP(B) 
 B S.E. Wald Df Sig. Exp(B) Lower Upper 
BA -4.758 2.020 5.55 1 .019 .009 .000 .450 
H -.123 .052 5.62 1 .018 .884 .798 .979 
PP .066 .037 3.27 1 .047 1.07 .994 1.148 
Constant 20.696 8.924 5.38 1 .020 973357650   
Note: Model’s final selected factors and their characteristics  
Table 6. The final factors included into the model and model characteristics 
 
 
Fig. 4. The logistic regression predictive model 
In the black box we have the equation for calculating the probability of having high-risk 
atherosclerosis, which is given by Y (Model’s outcome) = 20.696 – 4.758*b/a + 0.066*PP – 
0.123*H. Therefore, the probability of having high-risk atherosclerosis can be calculated as 
HRART = Exp (Y) / (1+Exp (Y)). This tells us that increasing the b/a value decreases the 
risk of atherosclerosis. Moreover, increasing PP increases the chance of being under high-
risk of atherosclerosis. Finally, increasing height decreases the risk of atherosclerosis. The 
classification table of the predictive model is shown in Table 7.  
 
Observed Predictive 
HRART Percentage correct 
No-risk High-risk 
Step 1  No-risk 24 10 70.6 
  High-risk 9 25 73.5 
 Overall percentage  
  
 
72.05 
Step 2  No-risk 25 9 73.5 
  High-risk 7 27 79.4 
 Overall percentage    76.5 
Note: Classification table based on backward: LR 
Table 7. Classification table of the predictive model 
Back Box 
PPG (b/a index)
HRART PP 
H 
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2. Agreement between the PPG and the CIMT 
We often hope to have data on, for example, atherosclerosis or arteriosclerosis where direct 
measurement without adverse effects is difficult or impossible. The true values remain 
unknown. Therefore, indirect methods are used, and a new method has to be evaluated by 
comparison with an established method rather than with the true quantity. If the new 
method agrees adequately well with the old one, the new one may be used as an alternative 
measure, or the old one may be replaced. In this work, CIMT is an established method for 
the measurement of atherosclerosis. The PPG as a new method comes into this work to 
assist or replace CIMT. And since CIMT is the used method, the convention of assisting or 
interchanging use of the two methods was employed.  
However, the Bland-Altman plot [69] is a graphical method to compare two measurement 
methods. In this graphical method the differences (or alternatively the ratios) between the 
two methods are plotted against the averages of the two methods. On the other hand [70] 
the differences can be plotted against one of the two methods, if this method is a reference 
or "gold standard" method. Horizontal lines are drawn at the mean difference, and at the 
limits of agreement, which are defined as the mean difference plus and minus 1.96 times the 
standard deviation of the differences. It is noteworthy that the agreement between the two 
methods must be done using the raw data (CIMT vs. b/a (PPG)). 
A comparison between CIMT and PPG in the measurement of high-risk atherosclerosis is 
plotted in Figure 5. PPG is a new non-invasive method. Here the mean difference is 0.05 
percentage points with a 95% confidence interval. The limits of agreement (-0.81 and 0.91) 
are small enough for us to be confident that the new method (PPG) can be used to assist 
CIMT for clinical purposes.  
 
Fig. 5. Agreement of CIMT and PPG in the measurement of risk atherosclerosis 
The plot reveals good agreement between the two methods, since the data are scattered 
around the mean. In addition, the mean value (0.05) is so close to zero that this strengthens 
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the agreement between CIMT and PPG. Such agreement raises the possibility of using PPG 
as an alternative rapid measure of high-risk atherosclerosis. 
3. Model performance  
The new proposed measure of high-risk atherosclerosis, (PPG’s b/a index), needs to be 
evaluated to be used in clinical settings. Basically, the performance of any established test or 
any newcomer test must be assessed. The diagnostic performance of a test or the accuracy of 
a test to discriminate risky cases from non risky cases is evaluated using Receiver Operating 
Characteristic (ROC) curve analysis [71-72]. ROC curves can also be used to compare the 
diagnostic performance of two or more laboratory or diagnostic tests [73]. Moreover, a 
measure of how well an index can distinguish between two diagnostic groups (risky/non 
risky) can be evaluated by the area under the ROC curve (AUC). Since the CIMT method 
continues to be a measure of atherosclerosis, the value of 0.7 was determined as the critical 
point. As a result, any value below or equal to 0.7 (CIMT=<0.7mm) represents a normal 
case, otherwise, it represents a case under risk. And since the diagnostic test is used to 
reveal the health status of the subject, a new index derived from CIMT which is called high-
risk atherosclerosis (HRART) is used to discriminate between at-risk-of-the-disease and 
normal subjects based on the critical value of 0.7.  HRART was taken as the dependent 
variable. Figure 6 demonstrates the error bar plot for b/a index based on HRART data. 
3434N =
Error bar of b/a index
HRART
high riskno risk
1.0
.9
.8
.7
.6
 
Fig. 6. Error bar of PPG (b/a index) based on HRART 
Statistically, an ROC curve provides an objective measure of the discriminatory power of a 
screening test and also an idea of where to place the cut-off point. Therefore, a ROC test 
(HRART vs. b/a) was run to obtain the sensitivity (the true positive rate) and the 100-
specificity (the false positive rate) for different cut-off points of the PPG (b/a ratio). MedCalc 
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software (version 11.4.4) was used to obtain the ROC curve and the AUC. The ROC curve 
for (HRART vs. b/a index) is shown in Figure 7. 
 
Fig. 7. ROC curve of HRART vs. PPG (b/a index) 
As seen in Figure7, the ROC curve revealed a sensitivity of 76.5% and a specificity of 64.7% 
in the discrimination between risky and normal subjects. A sensitivity of 75% would be 
reasonable [74-76]. When the probability of disease and the sensitivity and specificity of the 
test are known, the predictive value positive (PVP) and the predictive value negative (PVN) 
can be calculated [77]. Moreover, the combination of ROC curves for all model factors can be 
obtained to reflect the relationship between each factor and the dependent variable. The 
three factors (b/a index, PP and H) contributed by some means to the process of 
atherosclerosis. Figure 8 represents the ROC curves for all the model’s factors.  
The combined ROC for the model’s factors revealed the contribution of each factor to the 
development of atherosclerosis inside our arteries. As a result of that, each factor 
contributed separately to the atherosclerosis process, and all of them together contributed 
also to the process of atherosclerosis development partially. Partially means “not making a 
full contribution,” in other words, there are some other untested factors that might be 
contributing to atherosclerosis. However, the model produced a highly satisfactory 
Nagelkerke R-square value (0.372) which makes it a good rapid measure for the prediction 
of atherosclerosis risk. The effectiveness of the diagnosis is measured by the AUC.  
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Fig. 8. The obtained ROC curves for b/a index, PP and H 
3.1 Area Under the Curve (AUC) 
The correctness of any medical test depends on how well the test separates the sample being 
tested into those with or without the disease. The area under the ROC curve (AUC) is 
frequently used as a measure for the effectiveness of diagnostic markers [78]. Moreover, 
AUC is an overall test for the performance of the test. Statistically, the area of 1 represents a 
perfect test which rarely appears in real empirical data. The analysis of our data produced 
an AUC of 0.724, which is fair enough to ensure that the test is reliable in discrimination 
between normal and risky specimens. The details of the AUC obtained can be seen in  
Table 8.  
 
Variable  b/a index 
Classification variable HRART 
Sample size 68 
Positive group: HRART = 1 34 
Negative group: HRART = 0 34 
Disease prevalence (%) 50.0 
Area under the ROC curve (AUC) 0.724 
Standard error 0.06 
95% Confidence interval 0.6 to 0.83 
Z statistic  3.5 
Significance level P (Area = 0.5) 0.0004 
Table 8. The AUC obtained and its characteristics 
www.intechopen.com
 
Erectile Dysfunction – Disease-Associated Mechanisms and Novel Insights into Therapy 
 
208 
Basically, AUC can be interpreted as the probability that the test result from a randomly 
selected diseased subject is more indicative of disease than that from a randomly selected 
non-diseased subject. Therefore, getting a value of AUC to be 0.724 can be an indicator of 
the good performance of the developed predictive model. The interactive dot diagram 
(Figure 9) illustrates a sensitivity of 76.5% and a specificity of 64.7%. During the present 
study we defined normal subjects (without risk of atherosclerosis) who had a value of b/a 
index to be greater than 0.8. Otherwise, the subject will be diagnosed as a subject at risk of 
atherosclerosis, which in turn will make the subject aggressive about his/ her health status.   
ba
0.4
0.5
0.6
0.7
0.8
0.9
1.0
1.1
1.2
1.3
HRART
0 1
<=0.8033
Sens: 76.5
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Fig. 9. Interactive dot diagram of b/a index based on HRART 
In conclusion, this investigation introduced the acquired results based on our analysis. 
Moreover, a detailed discussion on the developed model and its characteristics were 
presented. The focus was completely on the association between atherosclerosis and the 
PPG signal indices. The developed model revealed a sensitivity of 76.5% and a specificity of 
64.7% which in turn suggested that it could be a rapid measure for the assessment of the 
prediction of high-risk atherosclerosis. Mainly, thinking of atherosclerosis to represent an 
important cause of ED raises the important of this developed model. As the developed 
model successes to predict high-risk atherosclerosis, it can be used to assist ED as well. 
Therefore, predicting the high-risk atherosclerosis at early stages could really improve the 
prevention of experiencing ED and improve the treatment methods. The analysis can be 
further extended to other cardiovascular risk factors such as hypertension, hyperlipidemia 
and smoking. These factors are not analyzed in this study due to limitation in the number of 
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subjects with one of the particular above mentioned risk factors. However, there is no doubt 
that the assessment of arterial stiffness and the assessment of high-risk atherosclerosis will 
make a major contribution to the improved management of cardiovascular disease in 
clinical settings and to the process of diseases prevention. 
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